Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
Copyright © 2021. Published by Elsevier Ltd..
As the COVID-19 pandemic continues, the availability of several different new vaccines, their varying supply levels, effectiveness, and immunity duration across different ethnic populations, together with natural infection rates, will have an impact on when each country can reach herd immunity (ranging from 15.3% to 77.1%). Here we estimate the population proportions still required to gain immunity (ranging from 0.01% to 48.8%) to reach an overall herd immunity level to stop the exponential virus spread in 32 selected countries.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
---|---|
Enthalten in: |
The Journal of infection - 83(2021), 3 vom: 01. Sept., Seite 381-412 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kwok, Kin On [VerfasserIn] |
---|
Links: |
---|
Themen: |
Basic reproductive number |
---|
Anmerkungen: |
Date Completed 06.09.2021 Date Revised 16.07.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jinf.2021.06.007 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326661794 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326661794 | ||
003 | DE-627 | ||
005 | 20231225195057.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jinf.2021.06.007 |2 doi | |
028 | 5 | 2 | |a pubmed24n1088.xml |
035 | |a (DE-627)NLM326661794 | ||
035 | |a (NLM)34118274 | ||
035 | |a (PII)S0163-4453(21)00287-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kwok, Kin On |e verfasserin |4 aut | |
245 | 1 | 0 | |a Will achieving herd immunity be a road to success to end the COVID-19 pandemic? |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.09.2021 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021. Published by Elsevier Ltd. | ||
520 | |a As the COVID-19 pandemic continues, the availability of several different new vaccines, their varying supply levels, effectiveness, and immunity duration across different ethnic populations, together with natural infection rates, will have an impact on when each country can reach herd immunity (ranging from 15.3% to 77.1%). Here we estimate the population proportions still required to gain immunity (ranging from 0.01% to 48.8%) to reach an overall herd immunity level to stop the exponential virus spread in 32 selected countries | ||
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Basic reproductive number | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Herd immunity | |
650 | 4 | |a Vaccination | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
700 | 1 | |a McNeil, Edward B |e verfasserin |4 aut | |
700 | 1 | |a Tsoi, Margaret Ting Fong |e verfasserin |4 aut | |
700 | 1 | |a Wei, Vivian Wan In |e verfasserin |4 aut | |
700 | 1 | |a Wong, Samuel Yeung Shan |e verfasserin |4 aut | |
700 | 1 | |a Tang, Julian Wei Tze |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 83(2021), 3 vom: 01. Sept., Seite 381-412 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
773 | 1 | 8 | |g volume:83 |g year:2021 |g number:3 |g day:01 |g month:09 |g pages:381-412 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.06.007 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 83 |j 2021 |e 3 |b 01 |c 09 |h 381-412 |